XM does not provide services to residents of the United States of America.
J
J

JPMorgan

Technical Summary

IndicatorValueTrend
IndicatorValueTrend
IndicatorValueTrend
IndicatorS3S2S1PR1R2R3

News

Novak: Russia will cut oil output in Q2 to catch up with other OPEC+ countries

UPDATE 1-Novak: Russia will cut oil output in Q2 to catch up with other OPEC+ countries Russia focuses on cuts in oil output, not exports in Q2 Russia to reduce oil output to 9 mln bpd in June - JPM Government orders firms to cut oil output to meet OPEC+ target Adds detail, quotes in paragraphs 8 and 9 By Olesya Astakhova MOSCOW, March 29 (Reuters) - Russia has decided to focus on reducing oil output rather than exports in the second quarter in order to evenly spread production cuts with other O
G
J
L

Rite Aid moves ahead on restructuring as sale efforts continue

Rite Aid moves ahead on restructuring as sale efforts continue By Dietrich Knauth NEW YORK, March 28 (Reuters) - Rite Aid, one of the largest U.S. pharmacy chains, received permission from a U.S. judge on Thursday to begin voting on a bankruptcy restructuring plan that would turn over most of the company's equity to its bondholders, while still leaving open the possibility of a sale.
J

Kitchen sponge maker Scrub Daddy explores sale, sources say

Kitchen sponge maker Scrub Daddy explores sale, sources say By Abigail Summerville March 28 (Reuters) - Scrub Daddy, the kitchen sponge maker that gained popularity after securing an investment on U.S. TV show "Shark Tank," is exploring options that include a sale of the company, according to people familiar with the matter. Scrub Daddy, which is backed by entrepreneur Lori Greiner, has hired JPMorgan Chase JPM.N to advise on whether and how its investors, that include its founder and chief exec
J
Q

Stoke Therapeutics eases after upsized $125 mln equity raise

BUZZ-Stoke Therapeutics eases after upsized $125 mln equity raise ** Shares of Stoke Therapeutics' STOK.O down 5.2% at $13.44 early Thurs after co raises more equity than targeted ** Co late Weds announced pricing offering of 9.3 mln shares, including pre-funded warrants to buy 3.7 mln shares, for $125 mln gross proceeds with JP Morgan as sole bookrunner ** STOK surged ~38% on Weds to close at $14.17, adding to 58% gain on Tues after co announced positive early-stage data for its epilepsy drug,
J

Sergio Ermotti has a path to Wall Street-style pay

BREAKINGVIEWS-Sergio Ermotti has a path to Wall Street-style pay The author is a Reuters Breakingviews columnist. The opinions expressed are his own. Updates to add graphic. By George Hay LONDON, March 28 (Reuters Breakingviews) - Sergio Ermotti is well rewarded or underpaid, depending on which side of the Atlantic you’re on. UBS UBSG.S on Thursday revealed it had handed its chief executive 14.4 million Swiss francs ($15.9 million) for the nine months since he returned to lead the Swiss lender
D
G
H
J
U
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.